Keyphrases
Pancreatic Cancer
100%
Tumor Cells
100%
Effector T Cells
100%
Neoadjuvant
100%
Radioimmunotherapy
100%
T Cell Infiltration
100%
Stereotactic Body Radiation
100%
Chemotherapy
66%
Programmed Death-ligand 1 (PD-L1)
66%
CD8+ T Cells
66%
Tumor Microenvironment
66%
M2-like
66%
Tumor-associated Macrophages
66%
Radiotherapy
33%
Clinical Trials
33%
Pancreatic Ductal Adenocarcinoma
33%
Effector Cells
33%
Neoadjuvant Therapy
33%
Long-term Survival
33%
Combination Treatment
33%
Increased Density
33%
Antitumor Immune Response
33%
Myeloid Cells
33%
Prolonged Survival
33%
T Helper 17 (Th17)
33%
Antibody Treatment
33%
Immune-modulating Effects
33%
Radiation Drive
33%
Locally Advanced PDAC
33%
Medicine and Dentistry
Tumor Cell
100%
Pancreas Cancer
100%
T Cell
100%
Cellular Infiltration
100%
Radioimmunotherapy
100%
Pancreatic Ductal Adenocarcinoma
100%
Whole Body Radiation
75%
Neoplasm
50%
Macrophage
50%
Cytotoxic T-Cell
50%
Tumor Microenvironment
50%
Radiation Therapy
25%
Pancreas Adenocarcinoma
25%
Immune Response
25%
Clinical Trial
25%
Neoadjuvant Therapy
25%
Effector Cell
25%
Immunosuppressive Drug
25%
Drive
25%
Myeloid Cell
25%
Programmed Death-Ligand 1
25%